|
gptkbp:instanceOf
|
gptkb:drug
antiretroviral therapy
|
|
gptkbp:activeIngredient
|
gptkb:tenofovir_alafenamide
bictegravir
emtricitabine
|
|
gptkbp:approvalYear
|
2018
|
|
gptkbp:ATCCode
|
gptkb:J05AR25
|
|
gptkbp:combinationTherapy
|
true
|
|
gptkbp:contraindication
|
severe liver impairment
concomitant use with dofetilide
|
|
gptkbp:drugClass
|
protease inhibitor
integrase strand transfer inhibitor
nucleotide reverse transcriptase inhibitor
|
|
gptkbp:form
|
gptkb:tablet
|
|
gptkbp:genericAvailable
|
false
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Biktarvy
|
|
gptkbp:indication
|
treatment of HIV-1 in children weighing at least 14 kg
treatment of HIV-1 in adults
|
|
gptkbp:legalStatus
|
Rx-only
|
|
gptkbp:manufacturer
|
gptkb:Gilead_Sciences
|
|
gptkbp:marketedIn
|
gptkb:Australia
gptkb:Canada
gptkb:European_Union
gptkb:Japan
gptkb:United_States
|
|
gptkbp:onceDaily
|
true
|
|
gptkbp:patent
|
gptkb:Gilead_Sciences
|
|
gptkbp:pregnancyCategory
|
consult physician
|
|
gptkbp:prescriptionRequired
|
https://www.gilead.com/-/media/files/pdfs/medicines/hiv/biktarvy/biktarvy_pi.pdf
|
|
gptkbp:prescriptionStatus
|
prescription only
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
nausea
diarrhea
fatigue
headache
insomnia
|
|
gptkbp:storage
|
room temperature
|
|
gptkbp:usedFor
|
HIV-1 infection
|
|
gptkbp:bfsParent
|
gptkb:Gilead_Sciences
gptkb:Gilead
|
|
gptkbp:bfsLayer
|
5
|